Advertisement
Screener

ARROWHEAD PHARMACEUTICALS, INC. (ARWR) Increase (Decrease) in Other Operating Liabilities

2.8 / 5 stars · 68/120 Roast Me

ARROWHEAD PHARMACEUTICALS, INC. Increase (Decrease) in Other Operating Liabilities

ARROWHEAD PHARMACEUTICALS, INC. (ARWR) reported Increase (Decrease) in Other Operating Liabilities of -$1.20 million for the 12-month period ending 2024-09-30, per its 10-K filed 2024-11-26.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2024-11-26

  • ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in other operating liabilities for the quarter ending 2022-09-30 was -$3.61M.
  • ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in other operating liabilities for the quarter ending 2022-06-30 was $2.68M, a 555.75% increase year-over-year.
  • ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in other operating liabilities for the quarter ending 2022-03-31 was $68.00K, a 93.99% decline year-over-year.
  • ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in other operating liabilities for the quarter ending 2021-12-31 was $922.00K.
  • ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in other operating liabilities for fiscal 2024 was -$1.20M.
  • ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in other operating liabilities for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
  • ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in other operating liabilities for fiscal 2022 was $65.00K.
  • ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in other operating liabilities for fiscal 2021 was -$169.00K, a 123.64% decline from fiscal 2020.
Period endIncrease (Decrease) in Other Operating Liabilities 3 monthIncrease (Decrease) in Other Operating Liabilities 3 month as first filedIncrease (Decrease) in Other Operating Liabilities 6 monthIncrease (Decrease) in Other Operating Liabilities 6 month as first filedIncrease (Decrease) in Other Operating Liabilities 9 monthIncrease (Decrease) in Other Operating Liabilities 9 month as first filedIncrease (Decrease) in Other Operating Liabilities 12 monthIncrease (Decrease) in Other Operating Liabilities 12 month as first filedIncrease (Decrease) in Other Operating Liabilities 98 monthIncrease (Decrease) in Other Operating Liabilities 101 monthIncrease (Decrease) in Other Operating Liabilities 104 monthIncrease (Decrease) in Other Operating Liabilities 107 monthIncrease (Decrease) in Other Operating Liabilities 110 monthIncrease (Decrease) in Other Operating Liabilities 113 monthIncrease (Decrease) in Other Operating Liabilities 116 monthIncrease (Decrease) in Other Operating Liabilities 119 monthIncrease (Decrease) in Other Operating Liabilities 122 monthIncrease (Decrease) in Other Operating Liabilities 125 monthIncrease (Decrease) in Other Operating Liabilities 128 monthIncrease (Decrease) in Other Operating Liabilities 131 month
2024-09-30-$1.20M
10-K · filed 2024-11-26
2023-09-30$0.00
10-K · filed 2024-11-26
2022-09-30-$3.61M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-26
-$925.00K
derived: sum of 2 quarters · filed 2024-11-26
-$857.00K
derived: sum of 3 quarters · filed 2024-11-26
$65.00K
10-K · filed 2024-11-26
2022-06-30$2.68M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-04
$2.75M
derived: sum of 2 quarters · filed 2022-08-04
$3.67M
10-Q · filed 2022-08-04
$2.82M
derived: sum of 4 quarters · filed 2023-11-29
2022-03-31$68.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-10
$990.00K
10-Q · filed 2022-05-10
$136.00K
derived: sum of 3 quarters · filed 2023-11-29
$545.00K
derived: sum of 4 quarters · filed 2023-11-29
2021-12-31$922.00K
10-Q · filed 2022-02-02
$68.00K
derived: sum of 2 quarters · filed 2023-11-29
$477.00K
derived: sum of 3 quarters · filed 2023-11-29
$1.61M
derived: sum of 4 quarters · filed 2023-11-29
2021-09-30-$854.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-29
-$445.00K
derived: sum of 2 quarters · filed 2023-11-29
$686.00K
derived: sum of 3 quarters · filed 2023-11-29
-$169.00K
10-K · filed 2023-11-29
$1.23M
10-K · filed 2021-11-22
2021-06-30$409.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-04
$1.54M
derived: sum of 2 quarters · filed 2022-08-04
$685.00K
10-Q · filed 2022-08-04
-$702.00K
10-Q · filed 2021-08-05
$98.00K
derived: sum of 4 quarters · filed 2022-11-28
2021-03-31$1.13M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-10
$276.00K
10-Q · filed 2022-05-10
-$497.00K
10-Q · filed 2021-05-04
-$311.00K
derived: sum of 3 quarters · filed 2022-11-28
$268.00K
derived: sum of 4 quarters · filed 2022-11-28
2020-12-31-$855.00K
10-Q · filed 2022-02-02
-$1.44M
derived: sum of 2 quarters · filed 2022-11-28
-$863.00K
derived: sum of 3 quarters · filed 2022-11-28
-$1.09M
derived: sum of 4 quarters · filed 2022-11-28
2020-09-30-$587.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-28
-$8.00K
derived: sum of 2 quarters · filed 2022-11-28
-$238.00K
derived: sum of 3 quarters · filed 2022-11-28
$715.00K
10-K · filed 2022-11-28
$2.23M
10-K · filed 2020-11-23
2020-06-30$579.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-05
$349.00K
derived: sum of 2 quarters · filed 2021-08-05
$1.30M
10-Q · filed 2021-08-05
$1.30M
10-Q · filed 2020-08-05
$2.95M
derived: sum of 4 quarters · filed 2021-11-22
2020-03-31-$230.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-04
$723.00K
10-Q · filed 2021-05-04
$725.48K
10-Q · filed 2020-05-07
$2.37M
derived: sum of 3 quarters · filed 2021-11-22
$2.07M
derived: sum of 4 quarters · filed 2021-11-22
2019-12-31$953.00K
10-Q · filed 2021-02-04
$953.19K
10-Q · filed 2020-02-05
$2.60M
derived: sum of 2 quarters · filed 2021-11-22
$2.30M
derived: sum of 3 quarters · filed 2021-11-22
$2.32M
derived: sum of 4 quarters · filed 2021-11-22
2019-09-30$1.64M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-22
$1.35M
derived: sum of 2 quarters · filed 2021-11-22
$1.37M
derived: sum of 3 quarters · filed 2021-11-22
$1.11M
10-K · filed 2021-11-22
$1.10M
10-K · filed 2019-11-25
2019-06-30-$297.28K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-05
-$272.18K
derived: sum of 2 quarters · filed 2020-08-05
-$538.02K
10-Q · filed 2020-08-05
-$640.31K
derived: sum of 4 quarters · filed 2020-11-23
2019-03-31$25.11K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-07
-$240.74K
10-Q · filed 2020-05-07
-$343.03K
derived: sum of 3 quarters · filed 2020-11-23
-$458.60K
derived: sum of 4 quarters · filed 2020-11-23
2018-12-31-$265.84K
10-Q · filed 2020-02-05
-$368.13K
derived: sum of 2 quarters · filed 2020-11-23
-$483.70K
derived: sum of 3 quarters · filed 2020-11-23
-$724.04K
derived: sum of 4 quarters · filed 2020-11-23
2018-09-30-$102.29K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-23
-$217.86K
derived: sum of 2 quarters · filed 2020-11-23
-$458.20K
derived: sum of 3 quarters · filed 2020-11-23
-$414.29K
10-K · filed 2020-11-23
2018-06-30-$115.57K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-05
-$355.91K
derived: sum of 2 quarters · filed 2019-08-05
-$312.00K
10-Q · filed 2019-08-05
-$321.83K
derived: sum of 4 quarters · filed 2019-11-25
2018-03-31-$240.34K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-08
-$196.43K
10-Q · filed 2019-05-08
-$206.26K
derived: sum of 3 quarters · filed 2019-11-25
-$331.73K
derived: sum of 4 quarters · filed 2019-11-25
2017-12-31$43.91K
10-Q · filed 2019-02-07
$34.08K
derived: sum of 2 quarters · filed 2019-11-25
-$91.39K
derived: sum of 3 quarters · filed 2019-11-25
$4.63K
derived: sum of 4 quarters · filed 2019-11-25
2017-09-30-$9.83K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-25
-$135.30K
derived: sum of 2 quarters · filed 2019-11-25
-$39.28K
derived: sum of 3 quarters · filed 2019-11-25
-$274.75K
10-K · filed 2019-11-25
2017-06-30-$125.47K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-07
-$29.45K
derived: sum of 2 quarters · filed 2018-08-07
-$264.92K
10-Q · filed 2018-08-07
-$158.03K
derived: sum of 4 quarters · filed 2018-12-11
2017-03-31$96.02K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-08
-$139.45K
10-Q · filed 2018-05-08
-$32.56K
derived: sum of 3 quarters · filed 2018-12-11
-$198.59K
derived: sum of 4 quarters · filed 2018-12-11
2016-12-31-$235.47K
10-Q · filed 2018-02-09
-$128.58K
derived: sum of 2 quarters · filed 2018-12-11
-$294.61K
derived: sum of 3 quarters · filed 2018-12-11
-$147.12K
derived: sum of 4 quarters · filed 2018-12-11
2016-09-30$106.89K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-11
-$59.14K
derived: sum of 2 quarters · filed 2018-12-11
$88.35K
derived: sum of 3 quarters · filed 2018-12-11
$131.14K
10-K · filed 2018-12-11
2016-06-30-$166.03K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-03
-$18.54K
derived: sum of 2 quarters · filed 2017-08-03
$24.25K
10-Q · filed 2017-08-03
-$47.77K
derived: sum of 4 quarters · filed 2017-12-12
2016-03-31$147.49K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-03
$190.28K
10-Q · filed 2017-05-03
$118.26K
derived: sum of 3 quarters · filed 2017-12-12
$115.47K
derived: sum of 4 quarters · filed 2017-12-12
2015-12-31$42.79K
10-Q · filed 2017-02-06
-$29.23K
derived: sum of 2 quarters · filed 2017-12-12
-$32.02K
derived: sum of 3 quarters · filed 2017-12-12
$3.21K
derived: sum of 4 quarters · filed 2017-12-12
2015-09-30-$72.02K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-12
-$74.81K
derived: sum of 2 quarters · filed 2017-12-12
-$39.58K
derived: sum of 3 quarters · filed 2017-12-12
-$40.38K
10-K · filed 2017-12-12
2015-06-30-$2.79K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-09
$32.44K
derived: sum of 2 quarters · filed 2016-08-09
$31.64K
10-Q · filed 2016-08-09
$130.38K
derived: sum of 4 quarters · filed 2016-12-14
2015-03-31$35.23K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-10
$34.42K
10-Q · filed 2016-05-10
$133.16K
derived: sum of 3 quarters · filed 2016-12-14
$343.01K
derived: sum of 4 quarters · filed 2016-12-14
2014-12-31-$802.00
10-Q · filed 2016-02-09
$97.94K
derived: sum of 2 quarters · filed 2016-12-14
$307.78K
derived: sum of 3 quarters · filed 2016-12-14
$316.27K
derived: sum of 4 quarters · filed 2016-12-14
2014-09-30$98.74K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-14
$308.59K
derived: sum of 2 quarters · filed 2016-12-14
$317.07K
derived: sum of 3 quarters · filed 2016-12-14
$94.26K
10-K · filed 2016-12-14
2014-06-30$209.85K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-04
$218.33K
derived: sum of 2 quarters · filed 2015-08-04
-$4.48K
10-Q · filed 2015-08-04
$120.96K
derived: sum of 4 quarters · filed 2015-12-14
2014-03-31$8.48K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-11
-$214.33K
10-Q · filed 2015-05-11
-$88.89K
derived: sum of 3 quarters · filed 2015-12-14
-$428.75K
derived: sum of 4 quarters · filed 2015-12-14
$727.92K
10-Q · filed 2014-05-06
2013-12-31-$222.81K
10-Q · filed 2015-02-09
-$97.37K
derived: sum of 2 quarters · filed 2015-12-14
-$437.24K
derived: sum of 3 quarters · filed 2015-12-14
-$424.93K
derived: sum of 4 quarters · filed 2015-12-14
$719.44K
10-Q · filed 2014-02-04
2013-09-30$125.44K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-14
-$214.43K
derived: sum of 2 quarters · filed 2015-12-14
-$202.12K
derived: sum of 3 quarters · filed 2015-12-14
-$187.91K
10-K · filed 2015-12-14
$942.25K
10-K · filed 2013-12-18
2013-06-30-$339.87K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-08-12
-$327.56K
derived: sum of 2 quarters · filed 2014-08-12
-$313.35K
10-Q · filed 2014-08-12
-$161.83K
derived: sum of 4 quarters · filed 2014-11-25
$816.81K
10-Q · filed 2013-08-07
2013-03-31$12.31K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-05-06
$26.52K
10-Q · filed 2014-05-06
$178.04K
derived: sum of 3 quarters · filed 2014-11-25
$71.58K
derived: sum of 4 quarters · filed 2014-11-25
$1.16M
10-Q · filed 2013-05-09
2012-12-31$14.21K
10-Q · filed 2014-02-04
$165.73K
derived: sum of 2 quarters · filed 2014-11-25
$59.27K
derived: sum of 3 quarters · filed 2014-11-25
$549.95K
derived: sum of 4 quarters · filed 2014-11-25
$1.14M
10-Q · filed 2013-02-13
2012-09-30$151.53K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-25
$45.06K
derived: sum of 2 quarters · filed 2014-11-25
$535.75K
derived: sum of 3 quarters · filed 2014-11-25
$882.30K
10-K · filed 2014-11-25
$1.13M
10-K · filed 2012-12-28
2012-06-30-$106.46K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-08-07
$384.22K
derived: sum of 2 quarters · filed 2013-08-07
$730.77K
10-Q · filed 2013-08-07
$698.72K
derived: sum of 4 quarters · filed 2013-08-07
$978.64K
10-Q · filed 2012-08-13
2012-03-31$490.68K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-05-09
$837.23K
10-Q · filed 2013-05-09
$805.19K
derived: sum of 3 quarters · filed 2013-05-09
$837.54K
derived: sum of 4 quarters · filed 2013-05-09
$1.09M
10-Q · filed 2012-05-08
2011-12-31$346.55K
10-Q · filed 2013-02-13
$314.50K
derived: sum of 2 quarters · filed 2013-02-13
$346.85K
derived: sum of 3 quarters · filed 2013-02-13
$378.31K
derived: sum of 4 quarters · filed 2013-02-13
$1.32M
10-Q · filed 2012-02-09
2011-09-30-$32.05K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-28
$302.00
derived: sum of 2 quarters · filed 2012-12-28
$31.76K
derived: sum of 3 quarters · filed 2012-12-28
$15.75K
10-K · filed 2012-12-28
$247.87K
10-Q · filed 2012-08-13
2011-06-30$32.35K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-08-13
$63.81K
derived: sum of 2 quarters · filed 2012-08-13
$47.80K
10-Q · filed 2012-08-13
$34.58K
derived: sum of 4 quarters · filed 2012-08-13
$1.01M
10-Q · filed 2011-08-08
2011-03-31$31.46K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-05-08
$15.45K
10-Q · filed 2012-05-08
$2.23K
derived: sum of 3 quarters · filed 2012-05-08
2010-12-31-$16.01K
10-Q · filed 2012-02-09
-$29.23K
derived: sum of 2 quarters · filed 2012-02-09
2010-09-30-$13.22K
derived: 10-K 12 month − 10-Q 9 month · filed 2011-12-20
$7.56K
10-K · filed 2011-12-20
2010-06-30$20.77K
10-Q · filed 2011-08-08

Similar stocks

Stock NameCountryMarket CapPE Ratio
CYTOKINETICS INC (CYTK)United States$9.130B-11.86
Protagonist Therapeutics, Inc (PTGX)United States$8.883B95.52
TG THERAPEUTICS, INC. (TGTX)United States$8.805B19.05
Axsome Therapeutics, Inc. (AXSM)United States$10.274B-66.82
Praxis Precision Medicines, Inc. (PRAX)United States$7.884B-27.60
Structure Therapeutics Inc. (GPCR)United States$7.710B-53.41
Spyre Therapeutics, Inc. (SYRE)United States$7.685B-43.69
Elanco Animal Health Inc (ELAN)United States$11.177B-61.80
IONIS PHARMACEUTICALS INC (IONS)United States$7.277B-23.25
Alkermes plc. (ALKS)$6.844B132.74